Owing Largely To Generic Erosion Of Key Agents, The ADHD Drug Market Will Decrease From $5 Billion In 2009 To $4.1 Billion In 2019

Sunday, Apr. 3rd 2011 6:24 AM

Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that the attention-deficit/hyperactivity disorder (ADHD) drug market in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan will fluctuate modestly over the next decade, decreasing from $5 billion in 2009 to a trough in 2013 before climbing to $4.

VN:F [1.9.22_1171]
Rating: 5.0/5 (1 vote cast)
VN:F [1.9.22_1171]
Rating: 0 (from 0 votes)
Owing Largely To Generic Erosion Of Key Agents, The ADHD Drug Market Will Decrease From $5 Billion In 2009 To $4.1 Billion In 2019, 5.0 out of 5 based on 1 rating
Posted on Sunday, Apr. 3rd 2011 6:24 AM | by Share of Cost | in Share of Cost | No Comments »

Leave a Reply